Published in Can Respir J on July 08, 2005
Factors affecting therapeutic compliance: A review from the patient's perspective. Ther Clin Risk Manag (2008) 3.75
Implementing practice guidelines: a workshop on guidelines dissemination and implementation with a focus on asthma and COPD. Can Respir J (2006) 1.32
Towards Excellence in Asthma Management: final report of an eight-year program aimed at reducing care gaps in asthma management in Quebec. Can Respir J (2008) 0.83
Electronic Adherence Monitoring in a High-Utilizing Pediatric Asthma Cohort: A Feasibility Study. JMIR Res Protoc (2016) 0.80
Factors associated with adherence to nucleos(t)ide analogs in chronic hepatitis B patients: results from a 1-year follow-up study. Patient Prefer Adherence (2015) 0.80
The paradox of adult asthma control: "who's in control anyway?". Can Respir J (2007) 0.78
Impact of Adding a Decision Aid to Patient Education in Adults with Asthma: A Randomized Clinical Trial. PLoS One (2017) 0.75
Systems Biology and Clinical Practice in Respiratory Medicine. The Twain Shall Meet. Am J Respir Crit Care Med (2016) 0.75
Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax (2012) 4.06
Inhaled corticosteroids in COPD and the risk of serious pneumonia. Thorax (2013) 3.62
Adult Asthma Consensus Guidelines update 2003. Can Respir J (2004) 3.61
Increased risk of childhood asthma from antibiotic use in early life. Chest (2007) 3.11
Bronchodilator use and the risk of arrhythmia in COPD: part 1: Saskatchewan cohort study. Chest (2012) 2.65
Should combination therapy with inhaled corticosteroids and long-acting beta2-agonists be prescribed as initial maintenance treatment for asthma? CMAJ (2002) 2.30
Fluoroquinolones and the risk of serious arrhythmia: a population-based study. Clin Infect Dis (2012) 2.17
Cardiovascular morbidity and mortality in COPD. Chest (2005) 2.01
Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. Am J Respir Crit Care Med (2007) 1.85
Gender differences in survival following hospitalisation for COPD. Thorax (2010) 1.73
The use of inhaled corticosteroids and the risk of adrenal insufficiency. Eur Respir J (2012) 1.67
Inhaled corticosteroids and the risks of diabetes onset and progression. Am J Med (2010) 1.66
Canadian Pediatric Asthma Consensus guidelines, 2003 (updated to December 2004): introduction. CMAJ (2005) 1.63
Airway remodeling in subjects with severe asthma with or without chronic persistent airflow obstruction. J Allergy Clin Immunol (2009) 1.52
Differences in airway remodeling between subjects with severe and moderate asthma. J Allergy Clin Immunol (2005) 1.52
Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes. J Allergy Clin Immunol (2006) 1.43
Bronchodilator use and the risk of arrhythmia in COPD: part 2: reassessment in the larger Quebec cohort. Chest (2012) 1.42
Increased expression of ADAM33 and ADAM8 with disease progression in asthma. J Allergy Clin Immunol (2007) 1.40
Differences in airway cytokine profile in severe asthma compared to moderate asthma. Chest (2007) 1.36
Implementing practice guidelines: a workshop on guidelines dissemination and implementation with a focus on asthma and COPD. Can Respir J (2006) 1.32
Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis. Gut (2013) 1.26
Geographic and gender variability in the prevalence of bronchial responsiveness in Canada. Chest (2004) 1.26
CNODES: the Canadian Network for Observational Drug Effect Studies. Open Med (2012) 1.26
Prevalence of obstructive sleep apnea-hypopnea in severe versus moderate asthma. J Allergy Clin Immunol (2009) 1.18
Childhood predictors of smoking in adolescence: a follow-up study of Montreal schoolchildren. CMAJ (2005) 1.16
Bias in observational study of the effectiveness of nasal corticosteroids in asthma. J Allergy Clin Immunol (2005) 1.14
Risks of pneumonia in patients with asthma taking inhaled corticosteroids. Am J Respir Crit Care Med (2010) 1.12
Implementation of a targeted screening program to detect airflow obstruction suggestive of chronic obstructive pulmonary disease within a presurgical screening clinic. Can Respir J (2015) 1.09
Inhaled and nasal corticosteroid use and the risk of fracture. Am J Respir Crit Care Med (2003) 1.07
T Cells localize with proliferating smooth muscle alpha-actin+ cell compartments in asthma. Am J Respir Crit Care Med (2010) 1.04
The Asthma Quiz for Kidz: a validated tool to appreciate the level of asthma control in children. Can Respir J (2004) 0.96
The determinants of prevalence of health complaints among young competitive swimmers. Int Arch Occup Environ Health (2006) 0.96
Adjustable maintenance dosing with budesonide/formoterol reduces asthma exacerbations compared with traditional fixed dosing: a five-month multicentre Canadian study. Can Respir J (2003) 0.95
Inhaled corticosteroids and risk of tuberculosis in patients with respiratory diseases. Am J Respir Crit Care Med (2010) 0.94
Oral corticosteroid use and the risk of acute myocardial infarction in chronic obstructive pulmonary disease. Can Respir J (2006) 0.93
Inhaled corticosteroid use in asthma and the prevention of myocardial infarction. Am J Med (2003) 0.91
The impact of over-the-counter simvastatin on the number of statin prescriptions in the United Kingdom: a view from the General Practice Research Database. Pharmacoepidemiol Drug Saf (2007) 0.90
TNF-alpha antagonists and the prevention of hospitalisation for chronic obstructive pulmonary disease. Pulm Pharmacol Ther (2007) 0.90
Symposium on obesity and asthma - November 2, 2006. Can Respir J (2007) 0.89
Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis. Arthritis Rheum (2006) 0.87
Effect of a web-based chronic disease management system on asthma control and health-related quality of life: study protocol for a randomized controlled trial. Trials (2011) 0.86
Airflow obstruction in young adults in Canada. Can Respir J (2007) 0.86
Discontinuation of Inhaled Corticosteroids in COPD and the Risk Reduction of Pneumonia. Chest (2015) 0.85
Women and asthma: lessons from a gender analysis of the asthma in Canada survey. J Asthma (2006) 0.85
Statins and the risk of interstitial lung disease: a cohort study. Thorax (2013) 0.84
Psychologic distress and maladaptive coping styles in patients with severe vs moderate asthma. Chest (2010) 0.83
Rates and patterns of chronic obstructive pulmonary disease exacerbations. Can Respir J (2004) 0.83
Development and validation of a predictive algorithm to identify adult asthmatics from medical services and pharmacy claims databases. Health Serv Res (2011) 0.83
Evaluating asthma control: a comparison of measures using an item response theory approach. J Asthma (2007) 0.83
Increased glucocorticoid receptor-beta expression, but not decreased histone deacetylase 2, in severe asthma. J Allergy Clin Immunol (2006) 0.83
Altitude-related hypoxia: risk assessment and management for passengers on commerical aircraft. Aviat Space Environ Med (2003) 0.82
Asthma and allergic rhinitis in Quebec children. Can Respir J (2004) 0.81
Correlates of quality of life in patients with asthma. Ann Allergy Asthma Immunol (2005) 0.81
Risk of glaucoma in elderly patients treated with inhaled corticosteroids for chronic airflow obstruction. Pulm Pharmacol Ther (2009) 0.81
Facilitators and solutions for practicing optimal guided asthma self-management: the physician perspective. Can Respir J (2013) 0.81
Pesticide exposure and asthma. Am J Respir Crit Care Med (2002) 0.80
Validation of The 30 Second Asthma Test as a measure of asthma control. Can Respir J (2007) 0.80
Newer disease-modifying antirheumatic drugs and the risk of serious hepatic adverse events in patients with rheumatoid arthritis. Am J Med (2004) 0.78
Effectiveness of combination therapies in asthma: an observational study. Pulm Pharmacol Ther (2008) 0.78
Safety and efficacy of HFA-134a beclomethasone dipropionate extra-fine aerosol over six months. Can Respir J (2004) 0.78
Integrated interdisciplinary care for patients with chronic obstructive pulmonary disease reduces emergency department visits, admissions and costs: a quality assurance study. Can Respir J (2013) 0.77
Evaluation of the use of an integrated drug information system by primary care physicians for vulnerable population. Int J Med Inform (2007) 0.77
Association between physician competence at licensure and the quality of asthma management among patients with out-of-control asthma. Arch Intern Med (2011) 0.76
β-blockers for COPD inpatients. Thorax (2012) 0.76
Predictors of perceived asthma control among patients managed in primary care clinics. Qual Life Res (2014) 0.76
A population-based evaluation of a regional asthma education centre. Can Respir J (2004) 0.76
Differences between asthmatics and nonasthmatics hospitalised with influenza A infection. Eur Respir J (2013) 0.75
Antibiotic therapy in patients hospitalized with acute chronic obstructive pulmonary disease. JAMA (2010) 0.75
The effects of a multisite aerobic exercise intervention on asthma morbidity in sedentary adults with asthma: the Ex-asthma study randomised controlled trial protocol. BMJ Open (2013) 0.75
Mega trials in COPD--clinical data analysis and design issues. Pneumonol Alergol Pol (2011) 0.75
Taking airway disease seriously. Thorax (2014) 0.75
Inhaled corticosteroids and fracture risk in COPD. Am J Respir Crit Care Med (2004) 0.75
How much did biases in the study of chronic obstructive pulmonary disease medications and mortality affect the outcome? Ann Intern Med (2009) 0.75
Asthma worsenings: approaches to prevention and management from the Asthma Worsenings Working Group. Can Respir J (2009) 0.75
Response. Chest (2013) 0.75
Environmental measures and asthma. Chest (2002) 0.75
Reply to Trezza et Al. Clin Infect Dis (2013) 0.75
Phenotypic heterogeneity of potentially curable non-small-cell lung cancer: cohort study with cluster analysis. J Thorac Oncol (2015) 0.75
Total and specific immunoglobulin E and their relationship to respiratory symptoms in Quebéc children and adolescents. Can Respir J (2005) 0.75
Teaching time for metered-dose inhalers in the emergency setting. Chest (2002) 0.75